当前位置: 首页 >> 检索结果
2061. [Colorectal adenoma-carcinoma. Guidelines and minimal diagnostic criteria. Italian Group for Pathology of the Digestive System].2062. [Guidelines for treatment of breast carcinoma by the Gynecological Oncology Working Group. Gynecological Oncology Working Group].
作者: H Concin.;W Grünberger.;E Kubista.;C Menzel.;H Pickel.;A Reiner.;W Seitz.;P Sevelda.;A Staudach.;M Widschwendter.;G Wolf.
来源: Gynakol Geburtshilfliche Rundsch. 1999年39卷4期226-9页 2063. Protocol for the examination of specimens from patients with carcinomas and malignant melanomas of the vulva: a basis for checklists. Cancer Committee of the American College of Pathologists.2064. Protocol for the examination of specimens from patients with carcinomas of the small intestine, including those with focal endocrine differentiation, exclusive of carcinoid tumors, lymphomas, and stromal tumors (sarcomas): a basis for checklists. Cancer Committee, American college of Pathologists.2065. Protocol for the examination of specimens from patients with hepatocellular carcinoma and cholangiocarcinoma, including intrahepatic bile ducts. Cancer Committee of the College of American Pathologists.2066. Protocol for the examination of specimens from patients with carcinomas of the gallbladder, including those showing focal endocrine differentiation: a basis for checklists. Cancer Committee of the College of American Pathologists.2067. Protocol for the examination of specimens from patients with endocrine tumors of the pancreas, including those with mixed endocrine and acinar cell differentiation: a basis for checklists. Cancer Committee of the College of American Pathologists.2068. Protocol for the examination of specimens from patients with carcinomas of the extrahepatic bile ducts, exclusive of sarcomas and carcinoid tumors: a basis for checklists. Cancer Committee of the College of American Pathologists.2069. Protocol for the examination of specimens from patients with carcinomas of the anus and anal canal: a basis for checklists. Cancer Committee of the College of American Pathologists.2070. Protocol for the examination of specimens from patients with malignant adrenal cortical tumors and pheochromocytomas, exclusive of neuroblastoma and other adrenal medullary tumors of childhood: a basis for checklists. Cancer Committee of the College of American Pathologists.2071. [Recommendations for reforming prostatic specimens. Les Membres du Sous-Comité Prostate du Comité de Cancerologie de l'Association Française d'Urologie].
作者: V Molinié.;A Vieillefond.;B Cochand-Priollet.;M C Dauge-Geffroy.;M A Lefrère-Belda.;M de Fromont.;A Lesourd.;M Toublanc.;N Berger.;R Bouvier.;A Villers.
来源: Ann Pathol. 1999年19卷6期549-56页
The purpose of these recommendations proposed by the members of the <<comités de Cancérologie de l'Association Française d'Urologie>>, is to provide an informative report for the clinician and the pathologist, in the management of patients with prostate cancer. These recommendations are common to the ADSAP and UICC recommendations on prostate cancer. Standardized forms are recommended to be included in every report.
2072. Recommendations for the reporting of tumors of the adrenal cortex and medulla. Association of Directors of Anatomic and Surgical Pathology.
The Association of Directors of Anatomic and Surgical Pathology has developed recommendations for the surgical pathology report for common malignant tumors. The recommendations for tumors of the adrenal cortex and medulla are reported herein.
2073. Guidelines for management of Bowen's disease. British Association of Dermatologists.
These guidelines for management of Bowen's disease have been prepared for dermatologists on behalf of the British Association of Dermatologists. They present evidence-based guidance for treatment, with identification of the strength of evidence available at the time of preparation of the guidelines, and a brief overview of epidemiological aspects, diagnosis and investigation.
2074. Consensus statements on radiation therapy of prostate cancer: guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. American Society for Therapeutic Radiology and Oncology Consensus Panel.
作者: J D Cox.;M J Gallagher.;E H Hammond.;R S Kaplan.;P F Schellhammer.
来源: J Clin Oncol. 1999年17卷4期1155页
To develop evidence-based guidelines for (1) prostate re-biopsy after radiation and (2) radiation therapy with rising prostate-specific antigen (PSA) levels after radical prostatectomy in the management of patients with localized prostatic cancer.
2075. [Breast cytology guidelines for a mammographic screening program. Report edited by the working group on "Breast Pathology in the Mammographic Screening Program" of the European Union].2076. Bladder cancer clinical guidelines panel summary report on the management of nonmuscle invasive bladder cancer (stages Ta, T1 and TIS). The American Urological Association.
作者: J A Smith.;R F Labasky.;A T Cockett.;J A Fracchia.;J E Montie.;R G Rowland.
来源: J Urol. 1999年162卷5期1697-701页
The American Urological Association convened the Bladder Cancer Clinical Guidelines Panel to analyze the literature regarding available methods of treating nonmuscle invasive bladder cancer, and to make practice policy recommendations based primarily on treatment outcomes data.
2077. [Management of an abnormal cervical smear. National Accreditation and Health Evaluation Agency].
来源: J Gynecol Obstet Biol Reprod (Paris). 1999年28卷4期310-8页
2078. The Royal College of Radiologists' Clinical Oncology Information Network. Guidelines on the non-surgical management of breast cancer.
来源: Clin Oncol (R Coll Radiol). 1999年11卷3期S90-133页
2079. Recommendations for reporting of tumors of the adrenal cortex and medulla. Association of Directors of Anatomic and Surgical Pathology.
来源: Mod Pathol. 1999年12卷8期835-9页
2080. Pathological evaluation of renal tumors in children: international society of pediatric oncology approach.
In the majority of European countries, children with renal tumors now enter the SIOP-93-01 Trial and Study. The objective of this Study is to refine methods of treatment especially in stage I patients. The role of institutional pathologists is important in this trial. There are new criteria for stages I and II, a new SIOP Working Classification of Renal Tumors of Childhood, and morphologic and prognostic similarities of pretreated and non-pretreated anaplastic cases. Specific problems encountered in assessing tumors treated with preoperative chemotherapy, administered to the majority of children over 6 months of age entering the SIOP Study, are discussed. The identification of a new low-risk group, the completely necrotic Wilms tumor, is outlined.
|